Bayer starts work on $43M+ expansion of OTC manufacturing site in Pennsylvania

SourceEndPoints News
Date Published12/02/2022
Author NameTyler Patchen
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Bayer Corporation
Parent companyBayer AG
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):75
Year reshoring announced:2022
Year reshoring implemented or to be implemented:2025
Capital investment ($):43.6
Country(ies) from which reshored:Germany
City reshored to:Myerstown
State(s) reshored to:PA
If relevant, work nearshored to:-
Product(s) reshoredpharma
What domestic positive factors made reshoring more attractive?Automation/technology, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market
Find Reshoring Articles